Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review

2017/02/23 by A. Jameera Begam, S. Jubie, M. J. Nanjan +1 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Bioactive Compounds and Antitumor Agents #Cytokine Signaling Pathways and Interactions #Estrogen and related hormone effects

paper · doi:10.1016/j.bioorg.2017.02.011

openalex publication_date 2017/02/23 · crossref created 2017/02/23 · crossref issued 2017/04/01 · crossref published 2017/04/01 · crossref published-print 2017/04/01 · crossref deposited 2019/09/18 · openalex created_date 2025/10/10 · crossref indexed 2026/04/03 · openalex updated_date 2026/07/28

Citations

• Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast
• Selective estrogen receptor modulators (SERMs): A review of clinical data
• Sulfonation and Molecular Action
• The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
• Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse
• Initial sequencing and analysis of the human genome
• Differential Response of Estrogen Receptor α and Estrogen Receptor β to Partial Estrogen Agonists/Antagonists
• 1-(Aminoalkyl)-2-phenylindoles as novel pure estrogen antagonists

Cited by

• Estrogen (medication) [wikipedia]